FDA 'Intercenter Institutes' Legislation Headed For Senate Mark-Up
FDA would be directed to test the concept of joint drug/device/diagnostic reviews in at least one therapeutic area; idea of further integrating medical product reviews is also part of Vice President’s cancer 'moonshot.'
You may also be interested in...
US FDA May Create Immunology, Neuroscience Centers Of Excellence
Commissioner Gottlieb says new centers would follow template of Oncology Center of Excellence.
Cures Bill Authorizes 'Intercenter Institutes,' But Will US FDA Create Them?
Agency is still working to get oncology center of excellence off the ground and has other large pending reorganizations that could take precedence.
Don't Rush To Reorganize FDA, McClellan Says
Former commissioner says agency has to think about getting biggest bang for the buck when considering a reorganization to disease-focused teams.